Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. The Company's subsidiary, Harvest Medicine provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by subaru1ion Mar 20, 2024 4:47pm
79 Views
Post# 35943685

RE:RE:RE:LABS said 'no' to AstraZeneca buyout offer....

RE:RE:RE:LABS said 'no' to AstraZeneca buyout offer....Garbage?  That's not garbage because you have to ask yourself, with all of the development work AstraZeneca has done with cannabinoids as active pharma ingredients and Pfizer taking out Seagen, a payload delivery mechanism, why did Astrazeneca purchase another 'payload delivery'....FUSN and skip over LABS....you better think that logic thru carefully buddy because there's tens of billions of dollars of future revenue on the line with cannabinoid pharma products.   

And if you don't like what I post, then put me on ignore rather than reflecting your frustrations like a baby with a wet diaper.  
<< Previous
Bullboard Posts
Next >>